Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Drug combination for reducing blood sugar and lipid levels and treating diabetes

A diabetes and composition technology, which is applied in the field of pharmaceutical compositions for reducing blood sugar and blood lipids and treating diabetes, can solve the problems of high cost and selling price, few action targets, and lack of links, and achieve low cost, no toxic and side effects, Effect of lowering blood sugar and blood fat

Inactive Publication Date: 2009-12-09
BEIJING LIQIANQIU SCI & TECH DEV
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0012] There are many types of medicines or health care products currently used to lower blood sugar and blood lipids, but there are few targets and links, which need to be improved, and there are many medicines with side effects, and the cost and price are very high

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Drug combination for reducing blood sugar and lipid levels and treating diabetes
  • Drug combination for reducing blood sugar and lipid levels and treating diabetes

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] Ophiopogon japonicus 7000mg,

[0027] Polygonatum 7000mg,

[0028] Vitamin B 1 3 mg,

[0029] Vitamin B 2 3 mg,

[0030] Vitamin B 6 2 mg,

[0031] Vitamin B 12 0.003mg,

[0032] Folic acid 0.3mg,

[0033] Zinc lactate (calculated as trace element zinc) 10mg,

[0034] Sodium selenate (calculated as trace element selenium) 0.02mg,

[0035] Chromium nicotinate (calculated as trace element chromium) 0.1mg,

[0036] Vitamin E (calculated as α-tocopherol equivalent) 10mg α-TE.

[0037] The above components were further uniformly mixed with appropriate amounts of additives such as magnesium aluminosilicate, polysolvate 60 and propylene glycol, and the resulting mixture was evenly filled into capsules to obtain 9 capsules, 3 times a day, 3 capsules each time .

Embodiment 2

[0039] Ophiopogon japonicus 7500mg,

[0040] Polygonatum 7500mg,

[0041] Vitamin B 1 3 mg,

[0042] Vitamin B 2 3 mg,

[0043] Vitamin B 6 2 mg,

[0044] Vitamin B 12 0.003mg,

[0045] Folic acid 0.3mg,

[0046] Niacinamide 10mg,

[0047] Zinc lactate (calculated as trace element zinc) 8mg,

[0048] Sodium selenate (calculated as trace element selenium) 0.02mg,

[0049] Chromium yeast (calculated as trace element chromium) 0.02mg,

[0050] Vitamin E (calculated as α-tocopherol equivalent) 10mg α-TE.

[0051] The above components were further uniformly mixed with appropriate amounts of additives such as magnesium aluminosilicate, polysolvate 60 and propylene glycol, and the resulting mixture was evenly filled into capsules to obtain 9 capsules, 3 times a day, 3 capsules each time .

Embodiment 3

[0053] Ophiopogon japonicus 8000mg,

[0054] Polygonatum 8000mg,

[0055] Vitamin B 1 3 mg,

[0056] Vitamin B 2 3 mg,

[0057] Vitamin B 6 2 mg,

[0058] Vitamin B 12 0.003mg,

[0059] Folic acid 0.3mg,

[0060] Niacinamide 10mg,

[0061] Zinc lactate (calculated as trace element zinc) 10mg,

[0062] Sodium selenate (calculated as trace element selenium) 0.02mg,

[0063] Chromium yeast (calculated as trace element chromium) 0.02mg,

[0064] Sodium molybdate (calculated as trace element molybdenum) 0.03mg,

[0065] Vitamin E (calculated as α-tocopherol equivalent) 10mg α-TE.

[0066] The above components were further uniformly mixed with appropriate amounts of additives such as magnesium aluminosilicate, polysolvate 60 and propylene glycol, and the resulting mixture was evenly filled into capsules to obtain 9 capsules, 3 times a day, 3 capsules each time .

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A drug combination for reducing blood sugar and lipid levels and treating diabetes comprises Ophiopogon japonicus (L.f) Ker-Gawl., Polygonatum sibiricum Red, vitamin B complex, vitamin E and trace elements such as zinc, selenium, chromium and molybdenum. The drug combination is mainly suitable for the population suffering from high blood sugar and lipid levels and diabetes, has good effects on reducing blood sugar and lipid levels and treating diabetes and can be taken for long term or according to the courses of treatment.

Description

Technical field: [0001] The invention relates to the technical field of medicine and health products; especially a pharmaceutical composition for lowering blood sugar and blood fat and treating diabetes. Background technique: [0002] The composition includes Ophiopogon japonicus, Rhizoma Polygonatum, complex vitamin B, vitamin E and trace elements zinc, selenium, chromium and molybdenum. [0003] Ophiopogon japonicus is a kind of natural Chinese herbal medicine that can be used as a health food for nourishing yin. It has the effects of nourishing the lungs and nourishing yin, nourishing the stomach and promoting body fluid, clearing the heart and eliminating troubles, and moistening the intestines. Insomnia, intestinal dryness and constipation; modern pharmacological studies have confirmed that Ophiopogon japonicus has: 1. Hypoglycemic effect; 2. Improving myocardial contractility and cardiac pump function; 3. Protecting myocardial function; 6. Anti-aging effect; 7. Enhanc...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/8969A61P3/06A61P3/10A61K31/191A61K31/197A61K31/355A61K31/4188A61K31/4415A61K31/455A61K31/51A61K31/519A61K31/525A61K31/714A61K33/04A61K33/24
Inventor 陈欣晶
Owner BEIJING LIQIANQIU SCI & TECH DEV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com